The roles of insulin and glucagon in the regulation of gluconeogenesis in the postabsorptive dog. 1977

A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005934 Glucagon A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) Glucagon (1-29),Glukagon,HG-Factor,Hyperglycemic-Glycogenolytic Factor,Proglucagon (33-61),HG Factor,Hyperglycemic Glycogenolytic Factor
D005943 Gluconeogenesis Biosynthesis of GLUCOSE from nonhexose or non-carbohydrate precursors, such as LACTATE; PYRUVATE; ALANINE; and GLYCEROL.
D000409 Alanine A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM. Abufène,Alanine, L-Isomer,L-Alanine,Alanine, L Isomer,L Alanine,L-Isomer Alanine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
April 1994, The American journal of physiology,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
February 1995, Journal of animal science,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
March 1997, The American journal of physiology,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
June 1975, Diabetes,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
October 1998, Metabolism: clinical and experimental,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
October 1987, Diabetologia,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
August 2005, American journal of physiology. Endocrinology and metabolism,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
April 2022, Journal of diabetes investigation,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
July 1974, The American journal of physiology,
A S Jennings, and A D Cherrington, and J E Liljenquist, and U Keller, and W W Lacy, and J L Chiasson
January 2018, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!